Granted Patent
B2
US 11,083,726 · App. 16/114,661 · Granted Aug 10, 2021
Methods and compositions for treating vasomotor symptoms
Inventors:
Robert A. Steiner (Seattle, WA); Charles Chavkin (Seattle, WA); Donald K. Clifton (Seattle, WA); Susan Reed (Seattle, WA); Victor Navarro (Seattle, WA)
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present disclosure is generally directed to compositions and methods for treating or limiting development of vasomotor symptoms in a subject.
Claims (1)
1. A method for treating or limiting the development of one or more vasomotor symptoms (VMS) in a female menopausal patient in need thereof, comprising administering estrogen to the patient for two to three months followed by treatment with an effective amount of osanetant, or a stereoisomer, mixture of stereoisomers, prodrug, pharmaceutically acceptable salt, hydrate, solvate, acid salt hydrate, N-oxide or isomorphic crystalline form thereof.
Assignments (4)
RELEASE OF SECURITY INTEREST
Recorded Apr 5, 2024
From: ZEVRA THERAPEUTICS INC. (AS SUCCESSOR IN INTEREST TO NANTAHALA CAPITAL MANAGEMENT, LLC, AS SUCCESSOR IN INTEREST TO SWK FUNDING LLC)
To: ACER THERAPEUTICS INC.
Reel/Frame 067020/0036 →
SECURITY INTEREST
Recorded Jul 6, 2023
From: SWK FUNDING LLC; ACER THERAPEUTICS INC
To: NANTAHALA CAPITAL MANAGEMENT, LLC
Reel/Frame 064167/0828 →
SECURITY INTEREST
Recorded Mar 11, 2022
From: ACER THERAPEUTICS INC.
To: SWK FUNDING LLC
Reel/Frame 059237/0638 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jun 30, 2021
From: STEINER, ROBERT A.; CHAVKIN, CHARLES; CLIFTON, DONALD K.; REED, SUSAN D.; NAVARRO, VICTOR M.
To: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
Reel/Frame 056724/0842 →
Continuity (6)
Continuation
14439585
Provisional Application
61732586
· Dec 3, 2012
Related Publication
20210030745A9
· Feb 4, 2021